IBO IMPACT BIOMEDICAL INC.

NYSE www.impactbiomedinc.com


$ 0.61 $ 0.01 (1.27 %)    

Wednesday, 15-Oct-2025 13:37:47 EDT
QQQ $ 601.68 $ -2.09 (-0.35 %)
DIA $ 462.52 $ -2.12 (-0.46 %)
SPY $ 664.63 $ -2.21 (-0.32 %)
TLT $ 90.60 $ -0.36 (-0.4 %)
GLD $ 387.23 $ 1.27 (0.33 %)
$ 0.613
$ 0.61
$ 0.60 x 1,500
$ 0.62 x 1,000
$ 0.60 - $ 0.61
$ 0.36 - $ 6.17
98,870
na
7.47M
$ 3.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-28-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 02-20-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this...

Core News & Articles

On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into a Debt Conversion Agreement...

 impact-biomedical-stock-is-soaring-monday-whats-going-on

Impact Biomedical, Inc. (AMEX:IBO) stock is trading higher Monday after the company announced a limited merger and share exchan...

Core News & Articles

Key Transaction TermsUnder the terms of the Merger Agreement, a merger subsidiary incorporated in Nevada as a PubCo subsidiary ...

Core News & Articles

Dr Ashleys Limited, a Hong Kong based global pharmaceutical company ("Dr Ashleys"), and Impact BioMedical Inc. ("Im...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION